Uploaded February 2026 | Updated November 2026, 1 hour ago
π¨ FreeStyle Libre 3 sensor recall β key facts
The FDA has updated its alert to classify this as a Class I recall.
In this video, Iβm covering the Libre 3 sensor recall and the recent FDA warning letter following FDAs inspection of the Libre factory in California, US.
π‘ Recall
β’ Some Libre 3 & Libre 3 Plus sensors
β’ Issue: inaccurate low glucose readings
β’ Lot-specific β not all sensors
β’ Affected users offered replacements π
β’ Check your sensor at π freestylecheck.com
π FDA inspection
β’ Libre manufacturing facility in Alameda, California
β’ Inspection date: 14 October 2025
π FDA warning letter
β’ Issued 23 January 2026 following the inspection
β’ Focused on procedures, processes, and documentation
β’ Abbott is actively working on addressing all points raised
π Big picture
β’ Dexcom has received a similar FDA warning letter following FDA inspections of its manufacturing facilities
I think itβs important that I report on safety, quality, and manufacturing issues β not just new device approvals etc.
If youβve got questions, drop them in the comments π¬
π£οΈPlease share this with anyone who uses Libre or needs to know.
#freestylelibre3 #sensorrecall #cgmlife #diabetestech #fda diabetescommunity nerdabetic
π¨ FreeStyle Libre 3 sensor recall β key facts
The FDA has updated its alert to classify this as a Class I recall.
In this video, Iβm covering the Libre 3 sensor recall and the recent FDA warning letter following FDAs inspection of the Libre factory in California, US.
π‘ Recall
β’ Some Libre 3 & Libre 3 Plus sensors
β’ Issue: inaccurate low glucose readings
β’ Lot-specific β not all sensors
β’ Affected users offered replacements π
β’ Check your sensor at π freestylecheck.com
π FDA inspection
β’ Libre manufacturing facility in Alameda, California
β’ Inspection date: 14 October 2025
π FDA warning letter
β’ Issued 23 January 2026 following the inspection
β’ Focused on procedures, processes, and documentation
β’ Abbott is actively working on addressing all points raised
π Big picture
β’ Dexcom has received a similar FDA warning letter following FDA inspections of its manufacturing facilities
I think itβs important that I report on safety, quality, and manufacturing issues β not just new device approvals etc.
If youβve got questions, drop them in the comments π¬
π£οΈPlease share this with anyone who uses Libre or needs to know.
#freestylelibre3 #sensorrecall #cgmlife #diabetestech #fda diabetescommunity nerdabetic










